ENDRA Life Sciences NDRA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4.53 | 51.18 | -3.25 | -1,622 | -3 | |
| 2025Q3 | 5.38 | 85.90 | -2.13 | -1,371 | -2 | |
| 2025Q2 | 3.51 | 106.12 | -1.71 | -1,301 | -1 | |
| 2025Q1 | 4.10 | 141.80 | -1.86 | -1,469 | -1 | |
| 2024Q4 | 6.26 | 103.57 | 25.20 | -4,297 | -4 | |
| 2024Q3 | 7.04 | 64.10 | 372.88 | -1,509 | -2 | |
| 2024Q2 | 169.93 | 100.09 | 0.00 | -2,231 | -2 | |
| 2024Q1 | 1015.00 | 100.18 | -455.02 | -2,781 | -3 | |
| 2023Q4 | 3710.00 | 99.86 | -93.87 | -1,458 | -1 | |
| 2023Q3 | 1942.68 | 100.90 | -572.88 | -3,129 | -3 | |
| 2023Q2 | 2450.00 | 117.08 | -472.52 | -2,995 | -3 | |
| 2023Q1 | 4007.33 | 99.90 | -1627.58 | -2,939 | -3 | |
| 2022Q4 | 7122.50 | 100.73 | -1802.59 | -3,313 | -3 | |
| 2022Q3 | 10710.00 | 99.33 | -1872.59 | -3,417 | -3 | |
| 2022Q2 | 8162.00 | 99.47 | -1977.60 | -3,572 | -4 | |
| 2022Q1 | 13650.00 | 99.90 | -2327.62 | -2,855 | -3 | |
| 2021Q4 | 24213.00 | 98.94 | -2712.64 | -3,072 | -3 | |
| 2021Q3 | 60550.00 | 99.70 | -2100.10 | -2,651 | -3 | |
| 2021Q2 | 76300.00 | 100.03 | -2800.14 | -3,200 | -3 | |
| 2021Q1 | 91000.00 | 113.53 | -2100.10 | -2,576 | -2 |